Business registries · firm from USPTO records
TransTech Pharma, Inc.
USPTO only Derived from USPTO records only (patent assignees and trademark owners); FURP found no state registration, Form D, Form ADV, nonprofit, SEC or lobbying record with this name and place.
- Place
- 4170 Mendenhall Oaks Parkway Suite 110, High Point, NC
- Entity type
- Corporation
- State of organization
- DE (as the owner states it in trademark filings)
- Patents
- 28 granted 2002-05-09 to 2015-06-02
- Trademarks
- 11, 8 live
- Record
- FUZZY medium confidence: USPTO records only: patent assignee and trademark owner with the same name (legal endings aside) and place
- Source
- USPTO: PVGPATDIS and TRCFECO2 (PVGPATDIS file of 2026-04-10, TRCFECO2 file of 2024-03-27); patent assignee and trademark owner with the same name (legal endings aside) and place
Patents
| Patent | Title | Granted | Source |
|---|---|---|---|
| US 9045461 | Phenyl-heteroaryl derivatives and methods of use thereof | 2015-06-02 | PVGPATDIS, file of 2026-04-10 |
| US 9034341 | Control of RAGE fusion protein glycosylation and RAGE fusion protein compositions | 2015-05-19 | PVGPATDIS, file of 2026-04-10 |
| US 8987295 | Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof | 2015-03-24 | PVGPATDIS, file of 2026-04-10 |
| US 8933222 | Oxadiazoanthracene compounds for the treatment of diabetes | 2015-01-13 | PVGPATDIS, file of 2026-04-10 |
| US 8877192 | Rage fusion proteins and methods of use | 2014-11-04 | PVGPATDIS, file of 2026-04-10 |
| US 8741900 | Phenyl-heteroaryl derivatives and methods of use thereof | 2014-06-03 | PVGPATDIS, file of 2026-04-10 |
| US 8718994 | Ligands for the GLP-1 receptor and methods for discovery thereof | 2014-05-06 | PVGPATDIS, file of 2026-04-10 |
| US 8703766 | Oxadiazoanthracene compounds for the treatment of diabetes | 2014-04-22 | PVGPATDIS, file of 2026-04-10 |
| US 8580833 | Substituted imidazole derivatives and methods of use thereof | 2013-11-12 | PVGPATDIS, file of 2026-04-10 |
| US 8524708 | Oxadiazoanthracene compounds for the treatment of diabetes | 2013-09-03 | PVGPATDIS, file of 2026-04-10 |
| US 8431575 | Phenyl-heteroaryl derivatives and methods of use thereof | 2013-04-30 | PVGPATDIS, file of 2026-04-10 |
| US 8404731 | Substituted imidazole derivatives, compositions, and methods of use as PTPase inhibitors | 2013-03-26 | PVGPATDIS, file of 2026-04-10 |
| US 8383644 | Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof | 2013-02-26 | PVGPATDIS, file of 2026-04-10 |
| US 8377983 | Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors | 2013-02-19 | PVGPATDIS, file of 2026-04-10 |
| US 8372988 | Crystalline forms of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine | 2013-02-12 | PVGPATDIS, file of 2026-04-10 |
| US 8344120 | Nucleic acid molecules encoding rage fusion proteins | 2013-01-01 | PVGPATDIS, file of 2026-04-10 |
| US 8211925 | Benzamide glucokinase activators | 2012-07-03 | PVGPATDIS, file of 2026-04-10 |
| US 8148413 | N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes | 2012-04-03 | PVGPATDIS, file of 2026-04-10 |
| US 7981424 | RAGE fusion proteins, formulations, and methods of use thereof | 2011-07-19 | PVGPATDIS, file of 2026-04-10 |
| US 7906507 | Oxadiazoanthracene compounds for the treatment of diabetes | 2011-03-15 | PVGPATDIS, file of 2026-04-10 |
| US 7884219 | Crystalline forms of [3-(4- {2-butyl- 1 -[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine | 2011-02-08 | PVGPATDIS, file of 2026-04-10 |
| US 7880012 | Benzamide glucokinase activators | 2011-02-01 | PVGPATDIS, file of 2026-04-10 |
| US 7820821 | Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors | 2010-10-26 | PVGPATDIS, file of 2026-04-10 |
| US 7790714 | Oxadiazoanthracene compounds for the treatment of diabetes | 2010-09-07 | PVGPATDIS, file of 2026-04-10 |
| US 7763726 | Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors | 2010-07-27 | PVGPATDIS, file of 2026-04-10 |
The newest 25 of 28. All patents of this assignee
Trademarks
| Mark | Serial | Filed | Status | Classes | Source |
|---|---|---|---|---|---|
| VTV THERAPEUTICS | 86594102 | 2015-04-10 | Abandoned | 044 | TRCFECO2, file of 2024-03-27 |
| VTV THERAPEUTICS | 86594096 | 2015-04-10 | Abandoned | 042 | TRCFECO2, file of 2024-03-27 |
| VTV THERAPEUTICS | 86594084 | 2015-04-10 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
| TTPSCREEN | 76406412 | 2002-05-13 | Registration cancelled | 042 | TRTYRAP, file of 2026-04-03 |
| TTPOSTGENE | 76406409 | 2002-05-13 | Registration cancelled | 042 | TRTYRAP, file of 2026-04-03 |
| TTPSPACE | 76406372 | 2002-05-13 | Registration cancelled | 042 | TRTYRAP, file of 2026-04-03 |
| TTP TRANSLATIONAL TECHNOLOGY | 76406371 | 2002-05-13 | Registration cancelled | 042 | TRTYRAP, file of 2026-04-03 |
| TTPREDICT | 76406330 | 2002-05-13 | Registration cancelled | 042 | TRTYRAP, file of 2026-04-03 |
| TRANSTECH PHARMA | 76406579 | 2002-05-09 | Registration cancelled | 040, 042 | TRTYRAP, file of 2026-04-03 |
| TRANSTECH PHARMA | 76406577 | 2002-05-09 | Registration cancelled | 040, 042 | TRTYRAP, file of 2026-04-03 |
| AT THE FRONTIER OF TRANSLATING INNOVATIVE SCIENCE INTO MEDICINE | 76404964 | 2002-05-09 | Registration cancelled | 042 | TRTYRAP, file of 2026-04-03 |
Possible related entities
- Pharmacore, Inc. firm from USPTO records, 3 trademarks FUZZY same street address (trademark filings)
Sharing an address can mean a parent and subsidiary, a shared office or a registered agent; it isn’t proof of a connection.
Firms here are built from USPTO patent assignees (PatentsView) and trademark owners: one firm per name (legal endings aside) and state, or country outside the US. Matches to other records are by name and state: EXACT means the identical full name, FUZZY a looser match, with the confidence shown.